Silencing of High Mobility Group Isoform I-C (HMGI-C) enhances paclitaxel chemosensitivity in breast adenocarcinoma cells (MDAMB-468)

Advanced Pharmaceutical Bulletin

Volumn 6, Issue 2, 2016, Pages 171-177

  Mansoori, Behzad ^a   Mohammadi, Ali ^a   Goldar, Samira ^a   Shanehbandi, Dariush ^a   Mohammadnejad, Leila ^a   Baghbani, Elham ^a   Kazemi, Tohid ^a   Kachalaki, Saeed ^a   Baradaran, Behzad ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Breast adenocarcinoma; HMGI C (High mobility group protein isoform I C); Paclitaxel; Small interference RNA (siRNA)

Indexed keywords

HIGH MOBILITY GROUP ISOFORM IC PROTEIN; HIGH MOBILITY GROUP PROTEIN; MESSENGER RNA; PACLITAXEL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HMGI C GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MDA MB 468 CELL LINE; MIGRATION INHIBITION; MTT ASSAY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING;

EID: 84980350575     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.15171/apb.2016.024     Document Type: Article

References (31)

1. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014;64(1):52-62. doi: 10.3322/caac.21203
2. Whelan J. First clinical data on rnai. Drug Discov Today 2005;10(15):1014-5. doi: 10.1016/S1359-6446(05)03547-6
3. Fire AZ. Gene silencing by double-stranded rna. Cell Death Differ 2007;14(12):1998-2012. doi: 10.1038/sj.cdd.4402253
4. Yazdi Samadi BVM. Genetics a molecular approach. Iran;Tehran University Publishers: Iran: Tehran University Publishers; 1388.
5. Kachalaki S, Baradaran B, Majidi J, Yousefi M, Shanehbandi D, Mohammadinejad S, et al. Reversal of chemoresistance with small interference rna (sirna) in etoposide resistant acute myeloid leukemia cells (hl-60). Biomed Pharmacother 2015;75:100-4. doi: 10.1016/j.biopha.2015.08.032
6. Mansoori B, Sandoghchian Shotorbani S, Baradaran B. Rna interference and its role in cancer therapy. Adv Pharm Bull 2014;4(4):313-21. doi: 10.5681/apb.2014.046
7. Mansoori B, Mohammadi A, Shir Jang S, Baradaran B. Mechanisms of immune system activation in mammalians by small interfering rna (sirna). Artif Cells Nanomed Biotechnol 2015:1-8. doi: 10.3109/21691401.2015.1102738
8. Narita M, Narita M, Krizhanovsky V, Nunez S, Chicas A, Hearn SA, et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 2006;126(3):503-14. doi: 10.1016/j.cell.2006.05.052
9. Reeves R. Molecular biology of hmga proteins: Hubs of nuclear function. Gene 2001;277(1-2):63-81.
10. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, et al. High level expression of the hmgi (y) gene during embryonic development. Oncogene 1996;13(11):2439-46.
11. Hirning-Folz U, Wilda M, Rippe V, Bullerdiek J, Hameister H. The expression pattern of the hmgic gene during development. Genes Chromosomes Cancer 1998;23(4):350-7.
12. Gattas GJ, Quade BJ, Nowak RA, Morton CC. Hmgic expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer 1999;25(4):316-22.
13. Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, et al. Hmgi-c expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 1996;149(3):775-9.
14. Meyer B, Loeschke S, Schultze A, Weigel T, Sandkamp M, Goldmann T, et al. Hmga2 overexpression in non-small cell lung cancer. Mol Carcinog 2007;46(7):503-11. doi: 10.1002/mc.20235
15. Abe N, Watanabe T, Suzuki Y, Matsumoto N, Masaki T, Mori T, et al. An increased high-mobility group a2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer 2003;89(11):2104-9. doi: 10.1038/sj.bjc.6601391
16. Malek A, Bakhidze E, Noske A, Sers C, Aigner A, Schafer R, et al. Hmga2 gene is a promising target for ovarian cancer silencing therapy. Int J Cancer 2008;123(2):348-56. doi: 10.1002/ijc.23491
17. Guang-meng XU, Hai-na Z, Xiao-feng T, Mei S, Xue-dong F. Effect of HMGA2 shRNA on the cell proliferation and invasion of human colorectal cancer sw480 cells in vitro. Chem Res Chinese Univ 2012;28(2):264-8.
18. Chau KY, Manfioletti G, Cheung-Chau KW, Fusco A, Dhomen N, Sowden JC, et al. Derepression of hmga2 gene expression in retinoblastoma is associated with cell proliferation. Mol Med 2003;9(5-8):154-65.
19. Miyazawa J, Mitoro A, Kawashiri S, Chada KK, Imai K. Expression of mesenchyme-specific gene hmga2 in squamous cell carcinomas of the oral cavity. Cancer Res 2004;64(6):2024-9.
20. Andrieux J, Demory JL, Dupriez B, Quief S, Plantier I, Roumier C, et al. Dysregulation and overexpression of hmga2 in myelofibrosis with myeloid metaplasia. Genes Chromosomes Cancer 2004;39(1):82-7. doi: 10.1002/gcc.10297
21. Lee YS, Dutta A. The tumor suppressor microrna let-7 represses the hmga2 oncogene. Genes Dev 2007;21(9):1025-30. doi: 10.1101/gad.1540407
22. Thuault S, Tan EJ, Peinado H, Cano A, Heldin CH, Moustakas A. Hmga2 and smads co-regulate snail1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem 2008;283(48):33437-46. doi: 10.1074/jbc.M802016200
23. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
24. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and hmga2 enhances oncogenic transformation. Science 2007;315(5818):1576-9. doi: 10.1126/science.1137999
25. Di Cello F, Hillion J, Hristov A, Wood LJ, Mukherjee M, Schuldenfrei A, et al. Hmga2 participates in transformation in human lung cancer. Mol Cancer Res 2008;6(5):743-50. doi: 10.1158/1541-7786.MCR-07-0095
26. Hristov AC, Cope L, Reyes MD, Singh M, Iacobuzio-Donahue C, Maitra A, et al. Hmga2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Mod Pathol 2009;22(1):43-9. doi: 10.1038/modpathol.2008.140
27. Chiappetta G, Ferraro A, Vuttariello E, Monaco M, Galdiero F, De Simone V, et al. Hmga2 mrna expression correlates with the malignant phenotype in human thyroid neoplasias. Eur J Cancer 2008;44(7):1015-21. doi: 10.1016/j.ejca.2008.02.039
28. Wu J, Liu Z, Shao C, Gong Y, Hernando E, Lee P, et al. Hmga2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of emt genes. Cancer Res 2011;71(2):349-59. doi: 10.1158/0008-5472.CAN-10-2550
29. Karami H, Baradaran B, Esfahani A, Estiar MA, Naghavi-Behzad M, Sakhinia M, et al. Sirna-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells. Asian Pac J Cancer Prev 2013;14(12):7719-24.
30. Karami H, Baradaran B, Esfehani A, Sakhinia M, Sakhinia E. Down-regulation of mcl-1 by small interference rna induces apoptosis and sensitizes hl-60 leukemia cells to etoposide. Asian Pac J Cancer Prev 2014;15(2):629-35.
31. Montazami N, Kheir Andish M, Majidi J, Yousefi M, Yousefi B, Mohamadnejad L, et al. Sirna-mediated silencing of mdr1 reverses the resistance to oxaliplatin in sw480/oxr colon cancer cells. Cell Mol Biol (Noisy-le-grand) 2015;61(2):98-103.